|
|
 |
|
Molecular Diagnostics Market: DNA Probes and Biochips -- New Product Development Opportunities and Business Expansion Strategies for Instrument and Reagent Suppliers
The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next ten years will witness significant developments in reagent systems and automation, as well as the introduction of a wide range of new products that will require innovative marketing approaches....
|
 |
|
$27500.00 |
| |
|
|
|
The 2009 Coagulation Testing Market: US, Europe, Japan - Emerging Business Opportunities and Market Expansion Strategies for Suppliers
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromagenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, computers and laboratory automation will radically change the coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation....
|
|
|
$23700.00 |
| |
|
|
|
Emerging markets series: Benchmarking key countries Brazil, Russia, India, China and Turkey
With dwindling growth rates observed in the major developed markets many pharmaceutical companies are turning towards emerging market countries in order to sustain their revenue growth. While some countries, with double digit growth rates present tremendous opportunities, there are also many obstacles that need to be overcome.
|
|
01/09/2008 |
$15200.00 |
| |
|
|
|
Top Ten Worlds Leading Pharmaceutical Companies
A thought-provoking report on performance, capabilities, goals and strategies of the major competitors in the worldwide pharmaceutical market. The report is designed to provide the pharmaceutical industry executives with strategically significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs....
|
|
|
$13200.00 |
| |
|
|
|
Top Ten World's Leading Diagnostic Imaging Companies
A unique multi-client study designed to provide diagnostic imaging industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, marketing and R&D programs. The study's major objectives include:- To establish a comprehensive, factual, annually updated and cost-effective information base on performance, capabilities, goals and strategies of the world's leading diagnostic imaging companies....
|
|
|
$12500.00 |
| |
|
|
|
Top Ten World's Leading Animal Health Companies
The report is designed to provide the animal health industry executives with strategically significant competitor information, analysis and insight, critical to the development and implementation of effective marketing and R&D programs. The study's major objectives include:- To establish a comprehensive, factual and cost-effective information base on performance, capabilities, goals and strategies of the world's leading animal health companies....
|
|
|
$11500.00 |
| |
|
|
|
Top Ten World's Leading Life Science Intermediates Companies
A strategic assessment of the competitive environment is widely recognized as one of the highest priority management responsibilities, the task crucial to business survival, growth and profitability. Timely and factual competitive intelligence is vital to the success of all business functions, particularly Planning, Marketing, R&D, and Manufacturing....
|
|
|
$11400.00 |
| |
|
|
|
Emerging pharmaceutical markets Argentina and Mexico
Latin American countries have attracted a lot of attention recently. With their economies currently stable, their geographic location and low-cost is ideal for investors....
|
|
03/12/2008 |
$7600.00 |
| |
|
|
|
US Molecular Diagnostics Market
This report presents a comprehensive analysis of the US molecular diagnostics market, including:- Major issues pertaining to the US molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods....
|
|
|
$7400.00 |
| |
|
|
|
The US Coagulation Market, 2009-2018
This report presents a comprehensive analysis of the US coagulation market, including: - Major issues pertaining to the US coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Ten-year volume and sales forecasts for 40 coagulation procedures performed in US hospitals, commercial laboratories, and physician offices, including typical coagulation daily work loads....
|
|
|
$7100.00 |
| |
|
|
|
Japanese Molecular Diagnostics Market
This report presents a comprehensive analysis of the Japanese molecular diagnostics market, including:- Major issues pertaining to the Japanese molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods....
|
|
|
$6500.00 |
| |
|
|
|
Almirall: PharmaVitae Profile
This analysis examines the historical and forecast performance for Almirall in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs....
|
|
04/12/2007 |
$5700.00 |
| |
|
|
|
Chugai Pharmaceutical Co., Ltd: PharmaVitae Profile
This analysis examines the historical and forecast performance for Chugai in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs....
|
|
10/18/2007 |
$5700.00 |
| |
|
|
|
Actelion Ltd: PharmaVitae Profile
This analysis examines the historical and forecast performance for Actelion in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information
|
|
10/18/2007 |
$5700.00 |
| |
|
|
|
Novo Nordisk A/S: PharmaVitae Profile
This analysis examines the historical and forecast performance for Novo Nordisk in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs....
|
|
10/31/2007 |
$5700.00 |
| |
|
|
|
The Pharmaceutical Industry 2008: Current and Future Trends and Strategic Issues Shaping Pharma
Today, pharma companies face growing competition from generics and me-too drugs, combined with increasingly tough P&R, a clamp down on healthcare spending, and the need to treat patients for longer due to the aging population. These factors threaten both current and future revenues prompting Pharma to adopt a range of corporate strategies to respond to the changing market dynamics.
|
|
03/20/2008 |
$5700.00 |
| |
|
|
|
The Japanese Coagulation Market, 2009-2018
This report presents a comprehensive analysis of the Japanese coagulation market, including: - Major issues pertaining to the Japanese coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- Ten-year volume and sales forecasts for 40 coagulation procedures performed in Japanese hospitals and commercial laboratories, including typical coagulation daily work loads....
|
|
|
$5400.00 |
| |
|
|
|
Spanish Molecular Diagnostics Market
This report presents a comprehensive analysis of the Spanish molecular diagnostics market, including:- Major issues pertaining to the Spanish molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
- An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods....
|
|
|
$5400.00 |
| |
|
|
|
|